Dose of ibrutinib in Waldenström macroglobulinaemia: Less can be more
Sign Up to like & getrecommendations! Published in 2023 at "British Journal of Haematology"
DOI: 10.1111/bjh.18664
Abstract: Ibrutinib changed the landscape of treatment in Waldenström macroglobulinaemia (WM) with excellent responses; however, there are high rates of dose reduction due to adverse events. The impact of this reduced dosing is unclear with regards… read more here.
Keywords: macroglobulinaemia less; dose ibrutinib; ibrutinib waldenstr; waldenstr macroglobulinaemia ... See more keywords